Jarne Elleholm
Fondateur chez Evodiabio ApS
Profil
Jarne Elleholm is the founder of Evodiabio ApS, established in 2021, where he is currently the Chairman.
He is also currently the Chairman of Ranger Biotechnologies A and Director of Touchlight Aquaculture Ltd.
Mr. Elleholm's former positions include Chief Executive Officer of Aqualife A and Lundbeck Ltd., Chairman of Zoetis Denmark ApS, Medotech A, and RSP Systems A, and Director of LiPlasome Pharma A and.
Action Pharma A.
He was also a Partner at Danmarks Eksport- og Investeringsfond from 2010 to 2012 and Managing Partner at Inventure Capital A from 2007 to 2010.
Mr. Elleholm holds an MBA from INSEAD and a graduate degree from Copenhagen Business School.
Postes actifs de Jarne Elleholm
| Sociétés | Poste | Début |
|---|---|---|
Ranger Biotechnologies A/S
 Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Président | - |
Touchlight Aquaculture Ltd.
 Touchlight Aquaculture Ltd. Miscellaneous Commercial ServicesCommercial Services Touchlight Aquaculture Ltd. is a British biotechnology company founded in 2020. The private company is based in Hampton, UK and engages in research and experimental development on biotechnology. | Directeur/Membre du Conseil | 07/05/2021 |
Evodiabio ApS
 Evodiabio ApS Food: Specialty/CandyConsumer Non-Durables Evodiabio ApS is a company based in Copenhagen, Denmark that is reinventing the production of natural aromas for a more sustainable world. Evodiabio is operating on the frontier of aromatic innovation and aims to revolutionize a wide range of industries category by category, starting with beer. The Danish company has reinvented natural aromas by fermentation, proposing a more environmentally friendly choice. Customers can order a free sample of their product, Yops™, for their brewery by filling in the fields on their website. The company was founded in 2021 by Simon Dusséaux, Sotirios Kampranis, Victor Forman, and Jarne Elleholm. Camilla Kloss Fenneberg has been the CEO of the company since 2021. | Fondateur | 01/01/2021 |
Anciens postes connus de Jarne Elleholm
| Sociétés | Poste | Fin |
|---|---|---|
Medotech A/S
 Medotech A/S Medical SpecialtiesHealth Technology Medotech A/S is a Danish biotech company with unique skills within the development and design of medical devices. Medotech's core competence is development of customised devices to register and analyse signals from the human body. The result of the analysis is returned to the body as bio-feedback. Medotech develops its solutions in cooperation with development departments, research institutes and other business partners in order to be able to supply professionally well- founded and thoroughly tested end products. Medotech's main product, GRINDCARE, has been developed in close cooperation with the Danish Technological Institute and the School of Dentistry at the University of Aarhus and a number of high-tech enterprises in Denmark. Medotech was founded by Faramarz Jadidi and is owned by a number of private and financial investors. | Président | 07/02/2014 |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Private Equity Investor | 01/07/2012 |
Inventure Capital A/S
 Inventure Capital A/S Investment ManagersFinance Inventure Capital A/S is a venture capital firm based in Aarhus, Denmark. Founded in 2006, the firm was established to manage several early-stage technology funds, namely INCUBA Venture, InnFond and Syddansk Kapital. | Private Equity Investor | 21/10/2010 |
Zoetis Denmark ApS
 Zoetis Denmark ApS Miscellaneous Commercial ServicesCommercial Services Zoetis Denmark ApS designs and manufactures diagnostic cartridges based on micro fluidic technology. Its technology enables veterinarians to obtain critical diagnostic information on their patients. The company was founded in 2000 and is headquartered in Farum, Denmark. | Président | - |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis. | Directeur/Membre du Conseil | - |
Formation de Jarne Elleholm
| INSEAD | Masters Business Admin |
| Copenhagen Business School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Inventure Capital A/S
Inventure Capital A/S Investment ManagersFinance Inventure Capital A/S is a venture capital firm based in Aarhus, Denmark. Founded in 2006, the firm was established to manage several early-stage technology funds, namely INCUBA Venture, InnFond and Syddansk Kapital. | Finance |
RSP Systems A/S
 RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Health Technology |
LiPlasome Pharma A/S
 LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology LiPlasome Pharma A/S develops, produces and supplies drugs for chemotherapy treatment. It has developed a technology based on incapsulation of chemotherapy in liposomes (fatty molecules) that will only dissolve in and around cancer tissue (tumors or metastases). The firm’s technology will improve chemotherapy treatment within a wide range of cancer diseases significantly as it improves the balance between effect and side effects. LiPlasome’s first drug candicate LiplaCis which is a liposonal formulation of Cisplatin, is in clinical phase 1. The company was founded in January 2001 by Ole Gunner Mouritsen and is headquartered in Hoersholm, Denmark. | Health Technology |
Aqualife A/S
 Aqualife A/S Air Freight/CouriersTransportation Aqualife A/S engages in the provision of logistical solutions for the fishing industry. It focuses on the transportation of fresh seafoods and live aquatic animals through its logistic system which includes freight, equipment, and services. The firm also engages in the establishment of land-based infrastructure for storage, cooling, and acclimatization. The company was founded by Maja Wall and Lars Nannerup on April 1, 2001 and is headquartered in Hellerup, Denmark. | Transportation |
Lundbeck Ltd.
 Lundbeck Ltd. Pharmaceuticals: MajorHealth Technology Lundbeck Ltd. engages in the research, development, production, marketing and sale of pharmaceuticals. It provides services that aid in the treatment of CNS disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. The company was founded in 1972 and is headquartered in St. Albans, the United Kingdom. | Health Technology |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis. | Health Technology |
Medotech A/S
Medotech A/S Medical SpecialtiesHealth Technology Medotech A/S is a Danish biotech company with unique skills within the development and design of medical devices. Medotech's core competence is development of customised devices to register and analyse signals from the human body. The result of the analysis is returned to the body as bio-feedback. Medotech develops its solutions in cooperation with development departments, research institutes and other business partners in order to be able to supply professionally well- founded and thoroughly tested end products. Medotech's main product, GRINDCARE, has been developed in close cooperation with the Danish Technological Institute and the School of Dentistry at the University of Aarhus and a number of high-tech enterprises in Denmark. Medotech was founded by Faramarz Jadidi and is owned by a number of private and financial investors. | Health Technology |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Finance |
Zoetis Denmark ApS
Zoetis Denmark ApS Miscellaneous Commercial ServicesCommercial Services Zoetis Denmark ApS designs and manufactures diagnostic cartridges based on micro fluidic technology. Its technology enables veterinarians to obtain critical diagnostic information on their patients. The company was founded in 2000 and is headquartered in Farum, Denmark. | Commercial Services |
Ranger Biotechnologies A/S
Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |
Touchlight Aquaculture Ltd.
Touchlight Aquaculture Ltd. Miscellaneous Commercial ServicesCommercial Services Touchlight Aquaculture Ltd. is a British biotechnology company founded in 2020. The private company is based in Hampton, UK and engages in research and experimental development on biotechnology. | Commercial Services |
Evodiabio ApS
Evodiabio ApS Food: Specialty/CandyConsumer Non-Durables Evodiabio ApS is a company based in Copenhagen, Denmark that is reinventing the production of natural aromas for a more sustainable world. Evodiabio is operating on the frontier of aromatic innovation and aims to revolutionize a wide range of industries category by category, starting with beer. The Danish company has reinvented natural aromas by fermentation, proposing a more environmentally friendly choice. Customers can order a free sample of their product, Yops™, for their brewery by filling in the fields on their website. The company was founded in 2021 by Simon Dusséaux, Sotirios Kampranis, Victor Forman, and Jarne Elleholm. Camilla Kloss Fenneberg has been the CEO of the company since 2021. | Consumer Non-Durables |
